E-LIB Suche - Ergebnisse für: J. Mascarenhas

1

53O Results from a phase II part I trial of mecbotamab vedo..:

Pollack, S. ; Conley, A.P. ; Tap, W.D....
ESMO Open. 9 (2024) - p. 102443 , 2024

Link: https://doi.org/10.1016/..

2

Quantitative autonomic testing after recovery from acute CO..:

Mascarenhas, L ; Kohno, R ; Mcdonald, D..
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROS..:

Harrison, C. ; Mascarenhas, J. ; Abraham, P....
HemaSphere. 6 (2022) - p. 947-948 , 2022

Link: https://doi.org/10.1097/..

4

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BL..:

Harrison, C. ; Rampal, R. K. ; Gupta, V....
HemaSphere. 6 (2022) - p. 920-921 , 2022

Link: https://doi.org/10.1097/..

5

Myocarditis post-SARS-CoV-2 vaccination: a systematic revie:

Goyal, M ; Ray, I ; Mascarenhas, D...
QJM: An International Journal of Medicine. 116 (2022) 1 - p. 7-25 , 2022

Link: https://doi.org/10.1093/..

6

P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO E..:

Mascarenhas, J. ; Harrison, C. N. ; Kiladjian, J.-J....
HemaSphere. 6 (2022) - p. 938-939 , 2022

Link: https://doi.org/10.1097/..

7

P1029: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PELA..:

Gupta, V. ; Mascarenhas, J. ; Kremyanskaya, M....
HemaSphere. 6 (2022) - p. 919-920 , 2022

Link: https://doi.org/10.1097/..

8

P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFET..:

Harrison, C. ; Mascarenhas, J. ; Rampal, R....
HemaSphere. 6 (2022) - p. 944-945 , 2022

Link: https://doi.org/10.1097/..

9

O089 Relationship of metformin with the risk of pancreatic ..:

Mascarenhas, A ; Adiamah, A ; Lobo, DN
British Journal of Surgery. 109 (2022) Supplement_4 - p. , 2022

Link: https://doi.org/10.1093/..

10

Local Failure in Non-Metastatic Ewing Sarcoma Patients Trea..:

Ahmed, S.K. ; Indelicato, D.J. ; Chuba, P.J....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S69-S70 , 2022

Link: https://doi.org/10.1016/..

11

Response to: Caution with the use of NSAIDs in myocarditis:

Goyal, M ; Ray, I ; Mascarenhas, D...
QJM: An International Journal of Medicine. 116 (2022) 2 - p. 154-155 , 2022

Link: https://doi.org/10.1093/..

12

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACR..:

Harrison, C. ; Bose, P. ; Mesa, R....
HemaSphere. 6 (2022) - p. 959-960 , 2022

Link: https://doi.org/10.1097/..

13

P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF..:

Mascarenhas, J. ; Gerds, A. T. ; Kish, J. K....
HemaSphere. 6 (2022) - p. 950-951 , 2022

Link: https://doi.org/10.1097/..

14

A system dynamics-based framework for examining Circular Ec..:

Guzzo, D. ; Pigosso, D.C.A. ; Videira, N..
Journal of Cleaner Production. 333 (2022) - p. 129933 , 2022

Link: https://doi.org/10.1016/..

15

S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUX..:

Mascarenhas, J. ; Kremyanskaya, M. ; Patriarca, A....
HemaSphere. 6 (2022) - p. 99-100 , 2022

Link: https://doi.org/10.1097/..